RAFFA WEALTH MANAGEMENT, LLC’s Recursion Pharmaceuticals RXRX Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29K	Buy	+351	New	+$1.17K	﹤0.01%	942

Other funds holding RXRX

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Kieckhefer Group Mequon, Wisconsin $246M AUM 51.29% 1-Year Est. Return

Themes Management Co Greenwich, Connecticut $151M AUM

RAFFA WEALTH MANAGEMENT, LLC's RXRX Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 351 shares worth $1.29K. The stake represents ﹤0.01% of the portfolio and ranks #942 among its holdings.

76 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 351 shares of Recursion Pharmaceuticals worth $1.29K as of Q2 2026.
Recursion Pharmaceuticals was a new RAFFA WEALTH MANAGEMENT, LLC position in Q2 2026.
Recursion Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #942 holding.
76 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.